BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND Ki-67 AND Clinical Outcome
34 results:

  • 1. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
    Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
    BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer.
    Cheng B; Ding K; Chen P; Ji J; Luo T; Guo X; Qiu W; Ma C; Meng X; Wang J; Yu J; Liu Y
    Cancer Commun (Lond); 2022 Jan; 42(1):17-36. PubMed ID: 34981670
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell lung cancer.
    Nanamiya R; Saito-Koyama R; Miki Y; Inoue C; Asavasupreechar T; Abe J; Sato I; Sasano H
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445227
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [The impact of CD8 and CTLA-4 expression on histopathological character and survival in mesothelioma].
    Yu M; Yu M; Ying SB; Yuan XY; Jiang ZQ; Lou JL; Zhu LJ; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):85-90. PubMed ID: 33691360
    [No Abstract]    [Full Text] [Related]  

  • 5. clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors.
    Nishii R; Saga T; Sudo H; Togawa T; Kuyama J; Tani T; Maeda T; Kobayashi M; Iizasa T; Shingyoji M; Itami M; Kawamura K; Hashimoto H; Yamazaki K; Tamura K; Higashi T
    Ann Nucl Med; 2021 Feb; 35(2):211-222. PubMed ID: 33387282
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Correlation of folate receptor alpha expression with clinicopathological parameters and outcome in triple negative breast cancer.
    Zagorac I; Lončar B; Dmitrović B; Kralik K; Kovačević A
    Ann Diagn Pathol; 2020 Oct; 48():151596. PubMed ID: 32829070
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With
    Palumbo B; Capozzi R; Bianconi F; Fravolini ML; Cascianelli S; Messina SG; Bellezza G; Sidoni A; Puma F; Ragusa M
    Anticancer Res; 2020 Jun; 40(6):3355-3360. PubMed ID: 32487631
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
    Milione M; Maisonneuve P; Grillo F; Mangogna A; Centonze G; Prinzi N; Pusceddu S; Garzone G; Cattaneo L; Busico A; Bossi P; Spaggiari P; Pellegrinelli A; Del Gobbo A; Ferrero S; Kankava K; Pruneri G; Rolli L; Roca E; Bercich L; Tironi A; Benvenuti MR; Gallazzi MS; Romano R; Berruti A; Pastorino U; Capella C
    Neuroendocrinology; 2021; 111(5):475-489. PubMed ID: 32365350
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Histologic Grading and ki-67 Index in Predicting outcomes in Pulmonary Carcinoid Tumors.
    Dermawan JKT; Farver CF
    Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mitosis count and number of cancer cells in cases of primary pulmonary adenocarcinoma: Correlations among phosphorylated histone 3, number of cancer cells, nuclear grade, pathologic features and prognosis.
    Inoue T; Nakazato Y; Karube Y; Maeda S; Kobayashi S; Chida M
    Pathol Int; 2018 Mar; 68(3):159-166. PubMed ID: 29393583
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [The clinical characteristics of pulmonary benign metastasizing leiomyoma].
    Wang HP; Shi JH; Zhang L
    Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):490-494. PubMed ID: 28693056
    [No Abstract]    [Full Text] [Related]  

  • 12. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
    Ohmoto A; Rokutan H; Yachida S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.
    Wen S; Zhou W; Li CM; Hu J; Hu XM; Chen P; Shao GL; Guo WH
    BMC Cancer; 2015 Jul; 15():520. PubMed ID: 26174366
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
    Jia C; Mei F; Zheng J; You JF; Liu JY
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
    Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
    Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. 3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
    Idema AJ; Hoffmann AL; Boogaarts HD; Troost EG; Wesseling P; Heerschap A; van der Graaf WT; Grotenhuis JA; Oyen WJ
    J Nucl Med; 2012 Dec; 53(12):1904-10. PubMed ID: 23077112
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Usefulness of ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas.
    Kim BH; Bae YS; Kim SH; Jeong HJ; Hong SW; Yoon SO
    APMIS; 2013 Feb; 121(2):105-10. PubMed ID: 23030396
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
    Shimizu K; Hirami Y; Saisho S; Yukawa T; Maeda A; Yasuda K; Nakata M
    Ann Thorac Surg; 2012 Feb; 93(2):398-403. PubMed ID: 22206958
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.
    van Boerdonk RA; Sutedja TG; Snijders PJ; Reinen E; Wilting SM; van de Wiel MA; Thunnissen FE; Duin S; Kooi C; Ylstra B; Meijer CJ; Meijer GA; Grünberg K; Daniels JM; Postmus PE; Smit EF; Heideman DA
    Am J Respir Crit Care Med; 2011 Oct; 184(8):948-56. PubMed ID: 21799074
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Global levels of histone modifications predict prognosis in different cancers.
    Seligson DB; Horvath S; McBrian MA; Mah V; Yu H; Tze S; Wang Q; Chia D; Goodglick L; Kurdistani SK
    Am J Pathol; 2009 May; 174(5):1619-28. PubMed ID: 19349354
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.